Open access peer-reviewed chapter

Is Anticancer Vaccine Possible: Experimental Application of Produced mRNA Transfected Dendritic Cells Derived from Enriched CD34+ Blood Progenitor Cells

By Paula Lazarova, Gunnar Kvalheim and Krassimir Metodiev

Submitted: July 12th 2012Reviewed: July 12th 2012Published: October 10th 2012

DOI: 10.5772/51544

Downloaded: 1609

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Paula Lazarova, Gunnar Kvalheim and Krassimir Metodiev (October 10th 2012). Is Anticancer Vaccine Possible: Experimental Application of Produced mRNA Transfected Dendritic Cells Derived from Enriched CD34+ Blood Progenitor Cells, Immunodeficiency Krassimir Metodiev, IntechOpen, DOI: 10.5772/51544. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/immunodeficiency/is-anticancer-vaccine-possible-experimental-application-of-produced-mrna-transfected-dendritic-cells" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

1609total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Immunoglobulin Treatment of Immunodeficient Patients

By Yıldız Camcıoğlu

Related Book

First chapter

Immunotherapy of Cancer — Some Up-To-Date Approaches

By Krassimir Metodiev, Paula Lazarova, Jon Kyte, Gunnar Kvalheim and Jahn Nesland

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us